Traci White
Family · Vancleave, MSNPI 1316483084
Payments from drug & device makers
Across 357 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$623
- Novo Nordisk$594
- Abbott$497
- Xeris Pharmaceuticals, Inc.$323
- AstraZeneca$280
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,835100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $1,581 |
| Lilly USA, LLC | 43 | $623 |
| Novo Nordisk | 44 | $594 |
| Abbott | 39 | $497 |
| Xeris Pharmaceuticals, Inc. | 19 | $323 |
| AstraZeneca | 14 | $280 |
| Renalytix AI, Inc. | 14 | $271 |
| Novartis | 8 | $147 |
| Bayer | 7 | $145 |
| Boehringer Ingelheim | 9 | $143 |
| Johnson & Johnson | 1 | $120 |
| Currax Pharmaceuticals LLC | 7 | $102 |
| Biohaven Pharmaceuticals, Inc. | 6 | $95 |
| Sanofi-aventis U.S. LLC | 6 | $93 |
| Corcept Therapeutics | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $77 |
| Pfizer | 4 | $70 |
| Exact Sciences | 4 | $66 |
| Merck | 3 | $61 |
| Medtronic | 4 | $56 |
| GSK | 3 | $49 |
| Grifols USA, LLC | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
| GRT US Holding, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$120
How this compares
$5,835 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $30,196 |
| TrulicityDulaglutide | 25 | $26,849 |
| OzempicSemaglutide | 27 | $26,205 |
| FarxigaDapagliflozin Propanediol | 22 | $19,102 |
| JardianceEmpagliflozin | 20 | $17,312 |
| EliquisApixaban | 18 | $14,230 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $9,371 |
| Risperidone OdtRisperidone | 13 | $3,018 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,863 |
| Atorvastatin Calcium | 172 | $1,196 |
| Omeprazole | 105 | $1,170 |
| Gabapentin | 92 | $1,113 |
| Amlodipine Besylate | 191 | $934 |
| Lisinopril | 151 | $854 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 31 | $823 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $623 | $57,04554 claims |
| Novo NordiskOzempic | $594 | $26,20527 claims |
| AstraZenecaFarxiga | $280 | $19,10222 claims |
| Boehringer IngelheimJardiance | $143 | $17,31220 claims |
| PfizerEliquis | $70 | $14,23018 claims |
| GSKTrelegy Ellipta | $49 | $9,37113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Vancleave
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.